"For the third consecutive year, U.S. News & World Report has named UT Southwestern Medical Center the No. 1 Best Hospital in Dallas-Fort Worth. Seven specialties were recognized as being among the best in the country. Zale Lipshy Pavilion - William P. Clements Jr. University Hospital is one of the world's premier neurological diagnostic and treatment centers. In addition to the neurosciences, the 148-bed Zale Lipshy Pavilion is also a treatment center for hematologic malignancies, ophthalmology, oral surgery, psychiatry, rehabilitation, and other services. Zale Lipshy University Hospital is located on Harry Hines Boulevard, in the Southwestern Medical District, just east of Interstate 35E, across from Parkland Memorial Hospital."

During the past decade, Zale Lipshy University Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 19 clinical trials were completed, i.e. on average, 316.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Zale Lipshy University Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 7 trials, followed by "Pfizer" with 7 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "Gynecologic Oncology Group" with 3 trials sponsored and "University of Texas Southwestern Medical Center" with 3 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Zale Lipshy University Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 9 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Medical University of South Carolina" with 2 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator and "Neurological Emergencies Treatment Trials Network (NETT)" with 2 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Zale Lipshy University Hospital" are "Cervical Adenocarcinoma" (3 trials), "Cervical Adenosquamous Carcinoma" (3 trials), "Recurrent Cervical Carcinoma" (3 trials), "Stage IVB Cervical Cancer" (3 trials) and "Breast Cancer" (2 trials). Many other conditions were trialed in "Zale Lipshy University Hospital" in a lesser frequency.

Most popular intervention types in "Zale Lipshy University Hospital" are "Drug" (23 trials), "Other" (11 trials), "Biological" (7 trials), "Procedure" (5 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (6 trials), "Placebo" (4 trials), "Bevacizumab" (3 trials), "Paclitaxel" (3 trials) and "Filgrastim" (2 trials). Other intervention names were less common.

The vast majority of trials in "Zale Lipshy University Hospital" are 19 trials for "All" genders and 12 trials for "Female" genders.

Currently, there are NaN active trials in "Zale Lipshy University Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Zale Lipshy University Hospital, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Zale Lipshy University Hospital, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".